List of Excipients in API emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Physicians Total Care Inc | COMPLERA | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 | ALUMINUM OXIDE | 2033-01-14 |
| Physicians Total Care Inc | COMPLERA | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 | CELLULOSE, MICROCRYSTALLINE | 2033-01-14 |
| Physicians Total Care Inc | COMPLERA | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 | CROSCARMELLOSE SODIUM | 2033-01-14 |
| Physicians Total Care Inc | COMPLERA | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 | FD&C BLUE NO. 2 | 2033-01-14 |
| Physicians Total Care Inc | COMPLERA | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 | FD&C YELLOW NO. 6 | 2033-01-14 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate
Excipient focus: ALUMINUM OXIDE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing ALUMINUM OXIDE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing CELLULOSE, MICROCRYSTALLINE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing CROSCARMELLOSE SODIUM
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing FD&C BLUE NO. 2
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing FD&C YELLOW NO. 6
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing FERRIC OXIDE RED
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 61958-1101 |
| REMEDYREPACK INC | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 70518-0677 |
| >Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 |
| >Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 61958-1101 |
| REMEDYREPACK INC | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 70518-0677 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing LACTOSE MONOHYDRATE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing MAGNESIUM STEARATE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 61958-1101 |
| REMEDYREPACK INC | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 70518-0677 |
| >Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 |
| >Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 61958-1101 |
| REMEDYREPACK INC | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 70518-0677 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing POLYSORBATE 20
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 61958-1101 |
| REMEDYREPACK INC | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 70518-0677 |
| >Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 |
| >Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 61958-1101 |
| REMEDYREPACK INC | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 70518-0677 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing STARCH, CORN
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing TITANIUM DIOXIDE
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing TRIACETIN
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Gilead Sciences Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 61958-1101 |
| REMEDYREPACK INC | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 70518-0677 |
| >Company | >Ingredient | >NDC |
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | 54868-6360 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
